Glucose transporter type 4 translocation machinery (GLUT4 translocation machinery)

The Glucose transporter type 4 (GLUT4) translocation machinery is a complex intracellular system responsible for the regulated movement of GLUT4 proteins from storage vesicles to the plasma membrane in response to insulin or exercise (Huang and Czech, 2007). This process is the rate-limiting step for glucose disposal in skeletal muscle and adipose tissue, making it a central component of systemic glucose homeostasis (Richter and Hargreaves, 2013). Key molecular players include the signaling kinases PI3K and Akt, the Rab-GAP protein AS160 (TBC1D4), and various SNARE proteins like VAMP2 and Syntaxin-4 that mediate vesicle fusion (Bogan, 2012). In states of insulin resistance and type 2 diabetes, this machinery is impaired, leading to reduced glucose uptake and hyperglycemia (Leto and Saltiel, 2012). Therapeutic agents such as insulin, metformin, and thiazolidinediones work by either directly activating or sensitizing the signaling pathways that drive this translocation process (PubChem, 2024). Emerging research also explores direct modulation of the trafficking proteins to bypass defective insulin signaling in metabolic diseases.

Other names

GLUT4 trafficking systemInsulin-responsive glucose transport systemGLUT4 vesicle translocation pathwayGLUT4 storage vesicle (GSV) machinery

Promotion of GLUT4 storage vesicle (GSV) fusion with the plasma membrane via activation of the PI3K/Akt/AS160 signaling axis or AMPK-mediated pathways (Leto and Saltiel, 2012; Bogan, 2012).